Preface

The journal Anti-Cancer Agents in Medicinal Chemistry has recently received its first impact factor of 3.144. I am sure this will encourage very high quality manuscript submissions going forward. I would like to take this opportunity to thank the authors for their excellent contributions, and the reviewers and Editorial Board Members for their precious assistance. I would like also to thank Ms. Madiha Zahoor and the entire staff of the Editorial Office of Bentham Science for their kind assistance. As Editor-in-Chief, I wish Anti-Cancer Agents in Medicinal Chemistry to become an expert forum to convey the latest research in medicinal chemistry and rational drug design for the discovery of new anti-cancer agents. In addition to review articles, Anti-Cancer Agents in Medicinal Chemistry is now publishing research papers which, like all manuscripts, are subjected to peer reviewing. Many Hot Topic Issues aim at providing readers with the latest developments on areas which are crucial for the progress of new therapeutic avenues. A part of the first 2012 Issue, proposed by J. Eswaran, is thematic and focuses on targeting G protein and phosphorylation dependent signalling molecules for anticancer therapy. In addition to a large number of general reviews and research articles in various exciting areas, the following thematic issues are also planned for the year 2012: novel therapeutic approaches for human cancers, recent developments of molecular targeted anti-cancer agents, new anti-cancer drugs from nature medicine and contrast agents in bio-medical imaging. I would like Anti-Cancer Agents in Medicinal Chemistry to be considered an indispensable source of knowledge by all scientists working in the field and to open up future prospects for them. I wish an excellent and fruitful year 2012 to the readers and members of the Editorial Board.